Serum microRNA-218 is a potential biomarker for esophageal cancer

Cancer Biomarkers

Volumn 15, Issue 4, 2015, Pages 381-389

  Jiang, Zhaojing ^a   Song, Qiancheng ^a   Yang, Suoping ^a   Zeng, Rong ^a   Li, Xufeng ^a   Jiang, Chunyu ^a,b   Ding, Weimin ^a   Zhang, Jiren ^a   Zheng, Yanfang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Anyang Cancer Hospital   (China)

Author keywords

cancer detection; Esophageal cancer; microRNA; microRNA 218; serum biomarker

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 16; MICRORNA 218; UNCLASSIFIED DRUG; MIRN218 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; EARLY DIAGNOSIS; ESOPHAGUS CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; AGED; BLOOD; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

AGED; BIOMARKERS, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; ROC CURVE;

EID: 84931089683     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-150480     Document Type: Article

References (39)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers and D.M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, International Journal of Cancer 127 (2010), 2893-2917.
2. M. Hongo, Y. Nagasaki and T. Shoji, Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity, Journal of Gastroenterology and Hepatology 24 (2009), 729-735.
3. F. Kamangar, R. Malekzadeh, S.M. Dawsey and F. Saidi, Esophageal cancer in northeastern Iran: A review, Archives of Iranian Medicine 10 (2007), 70-82.
4. Y. Xu, X. Yu, Q. Chen and W. Mao, Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma? World Journal of Surgical Oncology 10 (2012).
5. S. Kosugi, T. Nishimaki, T. Kanda, S. Nakagawa, M. Ohashi and K. Hatakeyama, Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients, World Journal of Surgery 28 (2004), 680-685.
6. B. Mroczko, M. Kozlowski, M. Groblewska, M. Lukaszewicz, J. Niklinski, W. Jelski, J. Laudanski, L. Chyczewski and M. Szmitkowski, The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients, Clinica Chimica Acta 389 (2008), 61-66.
7. S. Hirajima, S. Komatsu, D. Ichikawa, H. Takeshita, H. Konishi, A. Shiozaki, R. Morimura, M. Tsujiura, H. Nagata, T. Kawaguchi, T. Arita, T. Kubota, H. Fujiwara, K. Okamoto and E. Otsuji, Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma, British Journal of Cancer 108 (2013), 1822-1829.
8. J.T. Mendell, MicroRNAs - Critical regulators of development, cellular physiology and malignancy, Cell Cycle 4 (2005), 1179-1184.
9. D.P. Bartel, MicroRNAs: Target Recognition and Regulatory Functions, Cell 136 (2009), 215-233.
10. H. Yu, B. Duan, L. Jiang, M. Lin, H. Sheng, J. Huang and H. Gao, Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinumbased chemotherapy, American Journal of Translational Research 6 (2014), 71-77.
11. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris and C.M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets, Proceedings of the National Academy of Sciences of the United States of America 103 (2006), 2257-2261.
12. C.M. Croce and G.A. Calin, miRNAs, cancer, and stem cell division, Cell 122 (2005), 6-7.
13. T. Kan and S.J. Meltzer, MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma, Current Opinion in Pharmacology 9 (2009), 727-732.
14. G.A. Calin and C.M. Croce, MicroRNA signatures in human cancers, Nature Reviews Cancer 6 (2006), 857-866.
15. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin and M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences of the United States of America 105 (2008), 10513-10518.
16. T. El-Hefnawy, S. Raja, L. Kelly, W.L. Bigbee, J.M. Kirkwood, J.D. Luketich and T.E. Godfrey, Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics, Clinical Chemistry 50 (2004), 564-573.
17. N.B.Y. Tsui, E.K.O. Ng and Y.M.D. Lo, Stability of endogenous and added RNA in blood specimens, serum, and plasma, Clinical Chemistry 48 (2002), 1647-53.
18. M.P. Hunter, N. Ismail, X.L. Zhang, B.D. Aguda, E.J. Lee, L.B. Yu, T. Xiao, J. Schafer, M.L.T. Lee, T.D. Schmittgen, S.P. Nana-Sinkam, D. Jarjoura and C.B. Marsh, Detection of microRNA expression in human peripheral blood microvesicles, Plos One 3 (2008).
19. C.H. Lawrie, S. Gal, H.M. Dunlop, B. Pushkaran, A.P. Liggins, K. Pulford, A.H. Banham, F. Pezzella, J. Boultwood, J.S. Wainscoat, C.S.R. Hatton and A.L. Harris, Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma, British Journal of Haematology 141 (2008), 672-675.
20. H. Yu, L. Jiang, C. Sun, L. Guo, M. Lin, J. Huang and L. Zhu, Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer, Gene 534 (2014), 60-65.
21. Q. Chen, Q. Si, S. Xiao, Q. Xie, J. Lin, C. Wang, L. Chen, Q. Chen and L. Wang, Prognostic significance of serum miR-17-5p in lung cancer, Medical Oncology 30 (2013).
22. N. Liu, R.-X. Cui, Y. Sun, R. Guo, Y.-P. Mao, L.-L. Tang, W. Jiang, X. Liu, Y.-K. Cheng, Q.-M. He, W.C.S. Cho, L.-Z. Liu, L. Li and J. Ma, A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma, International Journal of Cancer 134 (2014), 1359-1368.
23. N. Takeshita, I. Hoshino, M. Mori, Y. Akutsu, N. Hanari, Y. Yoneyama, N. Ikeda, Y. Isozaki, T. Maruyama, N. Akanuma, A. Komatsu, M. Jitsukawa and H. Matsubara, Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma, British Journal of Cancer 108 (2013), 644-652.
24. J. Tie, Y. Pan, L. Zhao, K. Wu, J. Liu, S. Sun, X. Guo, B. Wang, Y. Gang, Y. Zhang, Q. Li, T. Qiao, Q. Zhao, Y. Nie and D. Fan, MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor, Plos Genetics 6 (2010).
25. T. Kinoshita, T. Hanazawa, N. Nohata, N. Kikkawa, H. Enokida, H. Yoshino, T. Yamasaki, H. Hidaka, M. Nakagawa, Y. Okamoto and N. Seki, Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma, Oncotarget 3 (2012), 1386-1400.
26. H. Xia, Y. Yan, M. Hu, Y. Wang, Y. Wang, Y. Dai, J. Chen, G. Di, X. Chen and X. Jiang, MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-kappa B activity, Neuro- Oncology 15 (2013), 413-422.
27. Y.-P. Sher, L.-J. Wang, L.-L. Chuang, M.-H. Tsai, T.-T. Kuo, C.-C. Huang, E.Y. Chuang and L.-C. Lai, ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells, Plos One 9 (2014).
28. A. Uesugi, K.-i. Kozaki, T. Tsuruta, M. Furuta, K.-i. Morita, I. Imoto, K. Omura and J. Inazawa, The tumor suppressive MicroRNA miR-218 targets the mTOR component rictor and inhibits AKT phosphorylation in oral cancer, Cancer Research 71 (2011), 5765-5778.
29. M. Yang, R. Liu, J. Sheng, J. Liao, Y. Wang, E. Pan, W. Guo, Y. Pu and L. Yin, Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma, Oncology Reports 29 (2013), 169-176.
30. Z. Chen, J. Li, L. Tian, C. Zhou, Y. Gao, F. Zhou, S. Shi, X. Feng, N. Sun, R. Yao, K. Shao, N. Li, B. Qiu, F. Tan and J. He, MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma, Cancer Letters 350 (2014), 34-42.
31. th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction, Annals of Surgical Oncology 17 (2010), 1721-1724.
32. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng and X. Du, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer, International Journal of Cancer 127 (2010), 118-126.
33. A.K. Akobeng, Understanding diagnostic tests 3: Receiver operating characteristic curves, Acta Paediatrica 96 (2007), 644-647.
34. S. Komatsu, D. Ichikawa, H. Takeshita, M. Tsujiura, R. Morimura, H. Nagata, T. Kosuga, D. Iitaka, H. Konishi, A. Shiozaki, H. Fujiwara, K. Okamoto and E. Otsuji, Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma, British Journal of Cancer 105 (2011), 104-111.
35. L. Song, Q. Huang, K. Chen, L. Liu, C. Lin, T. Dai, C. Yu, Z. Wu and J. Li, miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta, Biochemical and Biophysical Research Communications 402 (2010), 135-140.
36. N.M. Alajez, M. Lenarduzzi, E. Ito, A.B.Y. Hui, W. Shi, J. Bruce, S. Yue, S.H. Huang, W. Xu, J. Waldron, B. O'Sullivan and F.-F. Liu, miR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway, Cancer Research 71 (2011), 2381-2391.
37. J. Yu, Y. Wang, R. Dong, X. Huang, S. Ding and H. Qiu, Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion, Journal of Cancer Research and Clinical Oncology 138 (2012), 671-674.
38. S.-Y. Xin, X.-S. Feng, L.-Q. Zhou, J.-J. Sun, X.-L. Gao and G.-L. Yao, Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis, World Journal of Gastroenterology 20 (2014), 6906-6911.
39. H. Yu, G. Gao, L. Jiang, L. Guo, M. Lin, X. Jiao, W. Jia and J. Huang, Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer, International Journal of Clinical and Experimental Pathology 6 (2013), 2904-2911.